The same meal yields different numbers in different people, and the difference is enzymatic.
Serum triglycerides are set by two independent terms — what is made and what is removed — and removal is usually the variable one. It depends on the enzyme that hydrolyzes them at the capillary wall before tissue uptake (lipoprotein lipase), so an identical number can mean brisk production or slow clearance, and the two ask for different things. The wider cholesterol panel moves with it, though never as steeply.
Clearance is bought upstream. Energy sensing and the switch that stops fat storage lower what is made; insulin sensitivity, fasting insulin and blood-sugar handling decide how hard the liver is being pushed to make it; the master antioxidant and monocyte recruitment are what determine whether a raised number also becomes an inflamed vessel wall.
Three primary pathways of the nine it targets. A pathway opens only on graded, published evidence, shown with its source at the ingredient level.
Educational only. Not evaluated by the FDA.
The story of Triglyceride Decimator (Serum Lipid Reduction)
Triglyceride Decimator — ‘The Clearing House’ — for a number that has been going the wrong way. You have seen it on the sheet. One line among many, printed a little higher than last time, with a note to keep an eye on it. That line measures the fat traveling in your blood right now (serum triglycerides): the fuel your meals and your liver send into circulation, carried in particles like freight on a highway. Freight on a highway is supposed to be delivered. The trucks pull up alongside muscle and fat tissue, and a docking enzyme on the vessel wall unloads their cargo so the tissue can burn it or store it (lipoprotein lipase, the curbside unloader). When the unloader works, the trucks empty quickly and the highway clears. When it slows, the trucks keep circling, the number on the sheet climbs, and the leftover particles linger long enough to cause trouble in the vessel walls. That is why the number matters more than it seems. Triglycerides are not only fuel. They are a report card on how well the whole system handles fat, from how much the liver sends out to how quickly the tissues take delivery (lipid metabolism). Triglyceride Decimator runs a clearing house for that traffic. It speeds the unloader at the curb, helps the liver send out less freight in the first place, and keeps the handling of fats orderly across the whole system, so the highway runs clear between meals the way it was designed to. Clearance is bought upstream. Energy sensing and the switch that stops fat storage lower what is made; insulin sensitivity, blood-sugar support and fasting insulin decide how hard the liver is being pushed to make it; and the wider panel moves with it, so cholesterol falls where the triglycerides do, though never as steeply. The master antioxidant and monocyte recruitment decide whether a raised number also becomes an inflamed vessel wall — the difference between a figure on a page and a thing happening in an artery. The next time you read that line, it can be moving the right way.
Triglyceride & cholesterol crusher.
★ 5.0 · 200:1 · $99
The studies, ingredient by ingredient
Measured in people: a pooled analysis of over 100 human trials, backed by three further pooled analyses.
Two independent pooled analyses of human trials: triglycerides fell.
Pooled randomized trials in people with abnormal blood fats: triglycerides fell against control.
Shares allicin's human garlic evidence, deepening that case.
Three independent pooled analyses of human trials, robust with each trial removed in turn.
A formally graded pooled analysis of human trials; the effect held after every high-risk arm was removed.
Artichoke extract is standardized to this compound, so it carries the same human trials.
Measured in people: pooled randomized trials show meaningful long-term triglyceride lowering.
Measured in people: a pooled dose-against-response analysis across many randomized human trials.
Measured in people: a pooled analysis re-run with each trial removed in turn, plus two independent syntheses.
Two pooled analyses of human trials — one registered in advance, one run independently — arrive at the same direction of effect.
Measured in people: four independent pooled analyses report a reduction.
Measured in people: pooled human trials in women around and after menopause, plus an independent placebo-controlled trial.
In a randomized placebo-controlled trial in 151 women, serum triglyceride fell significantly, alongside liver fat and waist.
In a randomized double-blind crossover trial of 110 participants, triglyceride, total and LDL cholesterol all fell significantly.
Early human evidence, hedged: pooled randomized human trials exist.
Early human evidence in metabolic disease, with triglycerides lower.
Across 8 randomized trials in 716 patients, triglyceride fell 0.30 mmol/L.
Early human evidence, hedged: pooled randomized human trials exist.
A pooled analysis and an independent human trial both report lowering, making this an early but consistent human signal.
A resveratrol sugar-conjugate, carrying resveratrol's human evidence.
A pooled analysis of human trials reports a reduction in triglyceride.
Pooled human trials show it pulling disordered blood fats back toward normal.
In rodents with high blood fats, alfalfa's saponins turned down Hmgcr and Acat2, the genes that make and store cholesterol.
In rodents on a high-fat diet, nuciferine lowered both blood and liver fats.
In rodents, peanut shell's flavonoid-rich extract lowered lipid accumulation, and in cultured fat cells it induced browning.
Laboratory and animal studies only, pooled in a formal analysis of rodent studies that also appraised each one for bias.
In rats with high blood fats, adlay seed oil lowered LDL and abdominal fat and raised the blood's antioxidant defenses.
Total flavonoids lowered fats in rodents with high blood fats.
Paeonol, the fragrant compound of this Manchurian root, lowers the triglycerides a blood draw counts, and helps the liver clear fat.
The standardized extract lowered fats in two independent rodent models.
In laboratory testing, wild chrysanthemum lowered the markers of disordered blood fats.
Wogonin raised FGF21, a liver hormone that governs fat burning, and lowered triglycerides in mice made obese by diet.
These grades describe the maturity of the published science for each ingredient — not a claim that the product treats, cures, or is clinically proven for any goal. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.